{
  "company": {
    "name": "Adagene",
    "website": "https://adagene.com/",
    "record": "https://startuphistory.org/c/adagene.com"
  },
  "status": null,
  "history_since": "2011-02-02T14:22:32.000Z",
  "baseline": {
    "snapshot_id": "93c205edc810db686f2fe413e9aa0a736e0ef4013180f80b7e43ac48aeedaecc",
    "observed_at": "2011-02-02T14:22:32.000Z",
    "headline": "adagene.com",
    "description": null,
    "evidence": "https://web.archive.org/web/20110202142232/http://adagene.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [
            "$4.99 / mo",
            "$1.19 / mo"
          ],
          "compliance": [],
          "funding": []
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T14:15:24.513Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2011-02-02T14:22:32.000Z",
      "variants": [
        {
          "headline": "adagene.com",
          "subhead": null,
          "observed_at": "2011-02-02T14:22:32.000Z",
          "evidence": "https://web.archive.org/web/20110202142232/http://adagene.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "adagene.com",
      "subhead": null,
      "from": "2011-02-02T14:22:32.000Z",
      "to": "2011-02-02T14:22:32.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20110202142232/http://adagene.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2011-02-02T14:22:32.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T14:15:24.513Z",
      "variants": [
        {
          "headline": "Redefining the design and discovery of therapeutic antibodies",
          "subhead": null,
          "observed_at": "2022-01-11T04:02:34.000Z",
          "evidence": "https://web.archive.org/web/20220111040234/https://www.adagene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Redefining the design and discovery of therapeutic antibodies",
          "subhead": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.",
          "observed_at": "2023-01-12T00:03:32.000Z",
          "evidence": "https://web.archive.org/web/20230112000332/https://www.adagene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Redefining the design and discovery of therapeutic antibodies",
          "subhead": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.",
          "observed_at": "2024-01-04T12:19:25.000Z",
          "evidence": "https://web.archive.org/web/20240104121925/https://www.adagene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Redefining the design and discovery of therapeutic antibodies",
          "subhead": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.",
          "observed_at": "2025-07-17T10:58:34.000Z",
          "evidence": "https://web.archive.org/web/20250717105834/https://www.adagene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Redefining the design and discovery of therapeutic antibodies",
          "subhead": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.",
          "observed_at": "2026-06-13T19:10:24.000Z",
          "evidence": "https://web.archive.org/web/20260613191024/https://www.adagene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Redefining the design and discovery of therapeutic antibodies",
          "subhead": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.",
          "observed_at": "2026-10-11T21:36:55.000Z",
          "evidence": "https://web.archive.org/web/20261011213655/https://www.adagene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Redefining the design and discovery of therapeutic antibodies",
          "subhead": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.",
          "observed_at": "2026-10-15T04:34:45.000Z",
          "evidence": "https://web.archive.org/web/20261015043445/https://www.adagene.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Redefining the design and discovery of therapeutic antibodies",
          "subhead": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.",
          "observed_at": "2026-11-06T14:15:24.513Z",
          "evidence": "https://www.adagene.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Redefining the design and discovery of therapeutic antibodies",
      "subhead": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.",
      "from": "2022-01-11T04:02:34.000Z",
      "to": "2026-11-06T14:15:24.513Z",
      "captures": 8,
      "evidence": "https://www.adagene.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2022-01-11T04:02:34.000Z",
          "to": "2026-11-06T14:15:24.513Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-93c205edc810db686f2fe413e9aa0a736e0ef4013180f80b7e43ac48aeedaecc:f2e85ff16eafdad8ccff7a657f861f84ac2a10c881cd1bd047a0cd46d383bfc4:funding:db535bfc4be093a1",
      "before_evidence": "https://web.archive.org/web/20110202142232/http://adagene.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “The company has raised over $85 million through its series A to C financing.”.",
      "between": {
        "from": "2011-02-02T14:22:32.000Z",
        "to": "2018-08-23T01:16:20.000Z"
      },
      "evidence": "https://web.archive.org/web/20180823011620/http://www.adagene.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-c4c9c37309c88729fcdb88274ff638b714d4aff485f85fcfde40ed32783a8c5e:7da4a26b8fda1cbc72420bee337f73264c7791779c6d969934e0faa7252d2eb9:funding:4e04863d19f1e183",
      "before_evidence": "https://web.archive.org/web/20190917070955/http://www.adagene.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “The company has raised over $150 million through its series A to D financing.”.",
      "between": {
        "from": "2019-09-17T07:09:55.000Z",
        "to": "2020-07-17T16:00:49.000Z"
      },
      "evidence": "https://web.archive.org/web/20200717160049/http://www.adagene.com:80/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 3,
      "id": "page-7da4a26b8fda1cbc72420bee337f73264c7791779c6d969934e0faa7252d2eb9:a14c1677000e16b6e56b1fc2ad4a9c8109d6004eb60ce799b19697dc8c23074a:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20200717160049/http://www.adagene.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2020-07-17T16:00:49.000Z",
        "to": "2022-01-11T04:02:34.000Z"
      },
      "evidence": "https://web.archive.org/web/20220111040234/https://www.adagene.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Adagene” company record, https://startuphistory.org/c/adagene.com"
}